Claudia C. Bartolini

ARS Toscana, Florence, Italy, Italy

Poster(s):

• (8) Brodalumab Assessment of Hazards: A Multinational Safety (BRAHMS) Study of a Biological Anti-Psoriatic Drug Across Six European Countries
  Sunday, August 28, 2022

  8:00 AM – 1:45 PM CEST

• (Z) COVID-19 Infection and Medication Use in Pregnancy (CONSIGN) – A Multinational Drug Utilisation Study Using Linked Healthcare Data
  Sunday, August 28, 2022

  8:00 AM – 6:00 PM CEST

• (10) Exploring The Relationship Between Utilization Patterns of Biologic Disease-Modifying Anti-Rheumatic Drugs and Disease Activity in Rheumatoid Arthritis Patients
  Sunday, August 28, 2022

  8:00 AM – 1:45 PM CEST

• (198) Extracting Pregnancies from Heterogeneous Data Sources in Europe: A Novel Algorithm in The Conception Project
  Friday, August 26, 2022

  8:00 AM – 6:00 PM CEST

• (115) Evaluation of Drug-Utilization and Healthcare Facilities Use in Patients with Ulcerative Colitis and Treated with Biologic Therapy Using Data of An Italian Healthcare Administrative Database: Results from MICHELANGELO Study
  Saturday, August 27, 2022

  8:00 AM – 6:00 PM CEST

• (301) VAC4EU Active Safety Surveillance Study of The BNT162b2 COVID-19 Vaccine in Five European Countries: Study Design and First Results
  Sunday, August 28, 2022

  8:00 AM – 1:45 PM CEST

• (282) Validation to Estimate Sensitivity Along with Positive Predictive Value: A Case Study
  Saturday, August 27, 2022

  8:00 AM – 6:00 PM CEST